Detalles de la búsqueda
1.
Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum.
Curr Oncol Rep
; 26(1): 65-79, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38180692
2.
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape.
Curr Oncol Rep
; 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38652426
3.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682738
4.
Healthcare Professional Communication on Sexual Health: A Report from the Italian Working Group on Adolescents and Young Adults with Cancer.
Oncologist
; 28(10): e884-e890, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37348061
5.
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts.
Curr Oncol Rep
; 25(11): 1345-1362, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855848
6.
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
Support Care Cancer
; 31(7): 425, 2023 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358628
7.
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.
J Oncol Pharm Pract
; 29(7): 1748-1753, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37282554
8.
The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study.
Int J Mol Sci
; 24(2)2023 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36675262
9.
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
Cancer
; 128(16): 3067-3079, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35727053
10.
International Survey on Frailty Assessment in Patients with Cancer.
Oncologist
; 27(10): e796-e803, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35905085
11.
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Oncologist
; 27(12): e949-e956, 2022 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920559
12.
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel.
BMC Med
; 20(1): 48, 2022 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101049
13.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180954
14.
Risk of SARS-CoV2-Related Mortality in Non-Small Cell Lung Cancer Patients Treated with First-Line Immunotherapy Alone or in Combination with Chemotherapy.
Cancer Invest
; 40(5): 406-412, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34409906
15.
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group.
Curr Oncol Rep
; 24(7): 843-860, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320498
16.
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.
Curr Oncol Rep
; 24(12): 1851-1862, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255605
17.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539942
18.
The METeoric rise of MET in lung cancer.
Cancer
; 126(22): 4826-4837, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32888330
19.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32735386
20.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother
; 69(11): 2209-2221, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474768